EGFR Blood Monitoring

摘要

Improved methods of assessing status of a solid-tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.

主权项

1. A method of identifying a candidate non-small cancer cell lung cancer (NSCLC) patient for a targeted drug therapy, comprising:
detecting presence or absence of one or more mutated Epidermal Growth Factor Receptor (EGFR) sequence in blood from the patient; assessing metastatic status of the NSCLC patient as M1a or M1b; and, identifying the patient as a candidate for the targeted drug therapy based on at least the detected presence of the one or more mutated EGFR sequence in the blood of the patient, and the metastatic status of NSCLC in the patient.